Hong Kong Leveraging Home Court Advantage For Chinese Biotechs

The biggest shakeup of the Hong Kong Stock Exchange for three decades could see biotech businesses and innovators turn from West to East when seeking listings, as shown by plans being made by two prominent Chinese bioventures.